Trial · NCT06982859
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline in Total Clamp Disposition Index (cDI) for Comparison of Retatrutide With Placebo | Baseline, Week 28 | Change from baseline in total cDI for comparison of retatrutide with placebo |
| Secondary | Change from Baseline in cDI for Comparison Between Retatrutide and Semaglutide | Baseline, Week 28 | Change from baseline in total cDI for comparison between retatrutide and semaglutide |
| Secondary | Change from Baseline in Hyperinsulinemic Euglycemic Clamp M-value | Baseline, Week 28 | Change from baseline in hyperinsulinemic euglycemic clamp M-value |
| Secondary | Change from Baseline in First Phase Incremental Insulin Secretion Rate (ISR) | Baseline, Week 28 | Change from baseline in first phase ISR. |
| Secondary | Change from Baseline in Second Phase Total ISR | Baseline, Week 28 | Change from baseline in second phase total ISR |
| Secondary | Change from Baseline in Total ISR | Baseline, Week 28 | Change from baseline in total ISR |
| Secondary | Change from Baseline in Insulin Response to Arginine [Incremental Insulin Area Under the Curve (AUC) arginine, 0-10minutes] | Baseline, Week 28 | Change from baseline in insulin response to arginine \[Incremental Insulin AUC arginine, 0-10minutes\]. |
| Secondary | Change from Baseline in Insulin Response to Arginine (Incremental Insulin AUC arginine, 0-30minutes) | Baseline, Week 28 | Change from baseline in insulin response to arginine (Incremental Insulin AUC arginine, 0-30minutes). |
| Secondary | Change from Baseline in Beta-cell (β-cell) Glucose Sensitivity (GS) | Baseline, Week 28 | Change from baseline in β-cell GS. |
| Secondary | Change from Baseline in β-cell Glucose Sensitivity (GS) from Standardized Mixed-Meal Tolerance Test (sMMTT) | Baseline, Week 28 | Change from baseline in β-cell GS from sMMTT. |
| Secondary | Change from Baseline in ISR at Fixed Glucose Concentration (ISRg) from sMMTT | Baseline, Week 28 | Change from baseline in ISR at fixed glucose concentration (ISRg) from sMMTT |
| Secondary | Change from Baseline Fasting Glucose During sMMTT (Total and Incremental AUC0-240min) | Baseline, Week 28 | Change from baseline fasting glucose during sMMTT (total and incremental AUC0-240min) |
| Secondary | Change from Baseline Postmeal Glucose During sMMTT (Total and Incremental AUC0-240min) | Baseline, Week 28 | Change from baseline postmeal glucose during sMMTT (total and incremental AUC0-240min) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06982859/registered